Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v2-EN
Language English English
Date Updated 2023-01-17 2022-11-02
Drug Identification Number 02298619 02298619
Brand name ZELDOX ZELDOX
Common or Proper name ZELDOX ZELDOX
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients ZIPRASIDONE ZIPRASIDONE
Strength(s) 60MG 60MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 60
ATC code N05AE N05AE
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-23 2022-11-23
Estimated end date 2022-12-27 2022-12-27
Actual end date 2023-01-09
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments